Rankings
▼
Calendar
IMA Q4 2021 Earnings — ImageneBio Inc Revenue & Financial Results | Market Cap Arena
IMA
ImageneBio Inc
$69M
Q4 2021 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$20M
+31003.1% YoY
Gross Profit
$8M
39.0% margin
Operating Income
$3M
13.8% margin
Net Income
$3M
13.8% margin
EPS (Diluted)
$0.08
QoQ Revenue Growth
+439.7%
Cash Flow
Operating Cash Flow
-$13M
Free Cash Flow
-$14M
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$248M
Total Liabilities
$40M
Stockholders' Equity
$208M
Cash & Equivalents
$232M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$20M
$65,000
+31003.1%
Gross Profit
$8M
-$23M
+133.8%
Operating Income
$3M
-$26M
+110.7%
Net Income
$3M
-$26M
+110.7%
← FY 2021
All Quarters
Q1 2022 →